Healthcare

Healthcare

Johnson & Johnson Crushes Patent, Pricing Probs

Photo by hapabapa via iStock

The company is vying to become the first among its healthcare peers to make $100 billion in annual revenue.

2 min read

Photo via Xinhua/Sipa USA/Newscom

Technology

Wearable Wellness Devices Dominate CES as FDA Loosens Rules

Just last year, the FDA sent a warning letter to wellness wearable firm Whoop after it rolled out a feature to check users’ blood pressure.

1 min read
Photo via James Black/Icon Sportswire DHN/James Black/Icon Sportswire/Newscom

Healthcare

Asia Has Become ‘Epicenter’ of Prescription Drug Innovation: McKinsey

US firms are also staring down a multi-billion dollar patent cliff of their own, prompting a yearslong buying spree.

2 min read
Photo via Kris Tripplaar/Sipa USA/Newscom

Healthcare

Medline Surges After Year’s Most Valuable IPO

While 2025’s IPO boom is likely being enjoyed by Wall Street’s investment bankers, it may be even better news for private equity.

2 min read

Healthcare

Biotech Bill Bundled in Pentagon Spending Plan May Worsen Pharma’s Patent Cliff Dilemma

Photo via Graeme Sloan/Sipa USA/Newscom

The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf courses.

2 min read

Healthcare

Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion

Photo by SiyueSteuber via iStock

J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease.

2 min read

M&A

Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera

Photo via Mads Claus Rasmussen/ZUMAPRESS/Newscom

Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer’s bid of $8 billion.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.